27 September 2017
This is the BSI response to the publication of the 2016 - 17 immunisations statistics for England.
A presentation being made at the European Respiratory Society Congress in Milan today has reported on findings from a study examining the use of disinfectant by nurses and their subsequent likelihood of developing chronic obstructive pulmonary disease (COPD).
Our response to the Government commissioned report on the UK's Life Sciences Industrial Strategy
Our response to a study published in the Journal of Immunology looking at how carbon nanoparticles (such as those found in air pollution) can alter structure and function of certain proteins of the immune system.
Our response to a BMJ article calling for healthcare professionals to drop the message to 'complete the course' of antibiotics to avoid antibiotic resistance.
Our response to the Government's Joint Committee on Vaccination and Immunisation (JCVI) decision regarding extending Human Papilloma Virus (HPV) vaccination to adolescent boys.
Our response to research linking maternal sugar consumption during pregnancy to allergy in the offspring.
This BSI statement is in response to a ruling by the European Court of Justice (ECJ) on national courts deciding that vaccines may cause adverse reactions, even in the absence of scientific evidence.
The BSI has released a statement in response to a new report published by the Academy of Medical Sciences entitled ‘Enhancing the use of scientific evidence to judge the potential benefits and harms of medicines’.
Read our response to paper published in PLOS Pathogens on mutations in a strain of avian flu that could potentially allow this virus to be transmitted between humans.
Read our response to a paper published in JCI Insight on using a novel 'gene therapy' to treat allergy in mice.
Members of the public are invited to download the free #BritainBreathing app to track their seasonal allergy symptoms and to help researchers understand more about why the frequency of allergies is increasing.
A new survey has shown there are large variations in the use and interpretation of a new type of allergy test (component testing) by doctors in the UK and Europe. As a result of these findings, a new quality assurance scheme is being launched to ensure proper quality assessment and education about the performance and use of the tests. The paper was published in Clinical & Experimental Immunology.
The BSI has responded to a paper looking at if antibiotic use in mid-life has an effect on the subsequent likelihood of developing bowel cancer precursor.